Role of nitric oxide in mediating cardiovascular alterations accompanying heart failure in rats

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 6, 2004, Pages 372-379

  Da Cunha, Valdeci ^a   Stefanon, Ivanita ^a   Mill, José Geraldo ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Heart failure; Myocardial infarction; Nitric oxide; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIUM; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE RELAXATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; THICKNESS;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, CONGESTIVE; HEART RATE; MALE; NITRIC OXIDE; NITROPRUSSIDE; RATS; RATS, WISTAR; VASODILATION;

EID: 4544295302     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-038     Document Type: Article

References (32)

1. Bauersachs, J., Bouloumié, A., Fraccarollo, D., Hu, K., Busse, R., Ertl, G. 1999. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation, 100: 292-298.
2. Boer, R., Ulrich, W.-R., Klein, T., Mirau, B., Haas, S., Baur, I. 2000 The inhibitory potency and selectivity of arginine substrate site nitric oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol. Pharmacol. 58: 1026-1034.
3. Brandes, R.P., Walles, T., Koddenberg, G., Gwinner, W., Mugge, A. 1998. Endothelium-dependent vasodilation in Sprague-Dawley rats with postinfarction hypertrophy: lack of endothelial dysfunction in vitro. Basic Res. Cardiol. 93: 463-469.
4. Driss, A.B., Devaux, C., Henrion, D., Duriez, M., Thuillez, C., Levy, B.I., Michel, J.B. 2000. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation, 101: 2764-2770.
5. Finkel, M.S., Oddis, C.V., Mayer, O.H., Hattler, B.G., Simmons, R.L. 1995. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J. Pharmacol. Exp. Ther. 272: 945-952.
6. Feng, Q., Fortin, A.J., Lu, X., Arnold, O. 1999. Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur. J. Pharmacol. 376: 37-44.
7. Guyton, J.R., Hartley, C.J. 1985. Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am. J. Physiol. 248: H540-H546.
8. Hare, J.M., Givertz, M.M., Creager, M.A., Colucci, W.S. 1998. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation, 97: 161-166.
9. Heeneman, S., Leenders, P.J.A., Aarts, P.J.J.W., Smits, J.F.M., Arenas, J.W., Daemen, M.J.A.P. 1995. Peripheral vascular alterations during experimental heart failure in the rat. Do they exist? Arterioscler. Thromb. Vasc. Biol. 15: 1503-1511.
10. Heeneman, S., Smits, J.F., Leenders, P.J., Schiffers, P.M., Daemen, M.J. 1997. Effects of angiotensin II on cardiac function and peripheral vascular structure during compensated heart failure in the rat. Arterioscler. Thromb. Vasc. Biol. 17: 1985-1994.
11. Kauser, K., Da Cunha, V., Fitch, R., Mallari, C., Rubanyi, G.M. 2000. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol. 278: H1679-H1685.
12. Kelm, M., Schafer, S., Dahmann, R., Dolu, B., Perings, S., Decking, U.K., Schrader, J., Strauer, B.E. 1997. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc. Res. 36: 185-194.
13. Langille, B.L., Bendeck, M.P., Keeley, F.W. 1989. Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am. J. Physiol. 256: H931-H939.
14. Lindpaintner, K., Lu, W., Neidermajer, N., Schieffer, B., Just, H., Ganten, D., Drexler, H. 1993. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J. Mol. Cell Cardiol. 25: 133-143.
15. Mill, J.G., Stefanon, I., Leite, C.M., Vassallo, D.V. 1990. Changes in performance of the surviving myocardium after left ventricular infarction in rats. Cardiovasc. Res. 24: 748-753.
16. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 88: 1197-1201.
17. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 268: 26 286-26 295.
18. Mori, E., Haramaki, N., Ikeda, H., Imaizumi, T. 1998. Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxy nitrite in dogs. Cardiovasc. Res. 40: 113-123.
19. Ohashi, Y., Kawashima, S., Hirata, K., Yamashita, T., Ishida, T., Inoue, N., Sakoda, T., Kurihara, H., Yazaki, Y., Yokoyama, M. 1998. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J. Clin. Invest. 102: 2061-2071.
20. Ontkean, M., Gay, R., Greenberg, B. 1991. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ. Res. 69: 1088-1096.
21. Pernow, J., Wang, Q.D. 1999. The role of the L-arginine/nitric oxide pathway in myocardial ischemia and reperfusion injury. Acta Physiol. Scand. 167: 151-159.
22. Pfeffer, M.A., Pfeffer, J.M., Fishbein, M.C., Fletcher, P.J., Spadaro, J., Kloner, R.A., Braunwald, E. 1979. Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512.
23. Saito, T., Hu, F., Tayara, L., Fahas, L., Shennib, H., Giaid, A. 2002. Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am. J. Physiol. 283: H339-H345.
24. Schrier, R.W., Abraham, W.T. 1999. Hormones and hemodynamics in heart failure. N. Engl. J. Med. 341: 577-585.
25. Stathopulos, P.B., Lu, X., Shen, J., Scott, J.A., Hammond, J.R., McCormack, D.G., Arnold, J.M., Feng, Q. 2001. Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure. Am. J. Physiol. 80: H859-H867.
26. Takimoto, Y., Aoyama, T., Keyamura, R., Shinoda, E., Hattory, R., Yui, Y., Sasayama, S. 2000. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int. J. Cardiol. 76: 135-145.
27. Teerlink, J.R., Clozel, M., Fischli, W., Clozel, J.P. 1993. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J. Am. Coll. Cardiol. 22: 615-620.
28. Usui, M., Egashira, K., Kitamoto, S., Koyanagi, M., Katoh, M., Kataoka, C., Shimokawa, H., Takeshita, A. 1999. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 34: 546-551.
29. Vaziri, N.D., Ni, Z., Oveisi, F., Trnavsky-Hobbs, D.L. 2000. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36: 957-964.
30. Wang, D., Yang, X.P., Liu, Y.H., Carretero, O.A., LaPoint, M.C. 1999. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am. J. Hypertens. 12: 174-182.
31. Wildhirt, S.M., Suzuki, H., Wolf, W.P., Dudek, R., Horstman, D., Weismuller, S., Reichart, B. 1996. S-methylthiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem. Biophys. Res. Commun. 227: 328-333.
32. Zhu, B., Sun, Y., Sievers, R.E., Shuman, J.L., Glantz, S.A., Chatterjee, K., Parmley, W.W., Wolfe, C.L. 1996. L-arginine decreases infarct size in rats exposed to environmental tobacco smoke. Am. Heart J. 132: 91-100.